Exercise eases menopause symptoms, pooled trials suggest

The climacteric period involves endocrine change and symptoms that span several body systems, and those symptoms can erode health-related quality of life and psychological well-being. Many women either cannot use or would prefer not to use hormonal treatment, which puts a premium on non-pharmacological options that are cheap, widely available and carry few risks. Exercise is the obvious candidate, but it is not one thing: conventional aerobic and resistance training and mind-body practices may act differently on hot flushes, mood and general well-being. This review set out to ask whether randomised trials, taken together, show a consistent benefit and whether the type of exercise matters.

The authors ran a systematic review and meta-analysis of randomised controlled trials following the PRISMA 2020 statement, with the protocol registered prospectively in PROSPERO. They searched PubMed (MEDLINE), Scopus and Web of Science for trials published between January 2020 and September 2025 in women during the climacteric period. Risk of bias was judged with the Cochrane RoB tool and certainty of evidence with the GRADE approach. Twelve randomised trials with 1,050 participants were included, and the team pooled results using random-effects models, with prespecified subgroup analyses by exercise modality and leave-one-out sensitivity analyses.

Exercise was associated with significant improvement in menopausal symptomatology (Hedges' g = -2.10; 95% CI -4.14 to -0.06) and in health-related quality of life (Hedges' g = 1.41; 95% CI 0.46 to 2.36) versus control conditions. Anxiety fell by a mean difference of -1.20 (95% CI -1.52 to -0.88) and depressive symptoms by -1.17 (95% CI -1.40 to -0.94), both with far tighter intervals than the symptom and quality-of-life estimates. Leave-one-out sensitivity analyses supported the robustness of the pooled estimates, so no single trial was driving them. Exploratory subgroup analyses suggested effects may differ according to exercise modality, but these were not confirmatory.

The direction of these results is consistent with the long-standing view that physical activity supports mood and well-being, and extends it specifically to women in the menopausal transition using randomised evidence only. The wide confidence intervals around the symptom and quality-of-life effects, however, mean the magnitude is far less certain than the direction, and the authors themselves frame the conclusion as what the available evidence 'suggests'. Because the modality subgroups were exploratory, the review cannot say whether yoga-style mind-body work, aerobic training or resistance training is preferable for a given symptom. The authors argue for incorporating exercise into routine clinical care while emphasising individualised prescription.

For women going through the menopausal transition, this is a reason to think that structured exercise is a genuinely useful non-drug option rather than just general health advice, with the most reliably measured benefits here being on anxiety and depressive symptoms. It does not establish which form of exercise works best, how much is needed, or how long the improvements last, because the trials were small and diverse. The honest reading is that movement of several kinds appears to help across symptom, mood and quality-of-life measures. Anyone with menopausal symptoms weighing options can treat this as supportive context for a conversation with a clinician, not a prescription.